MOTS-c
Also known as: Mitochondrial ORF of the 12S rRNA type-c
A genuinely interesting mitochondrial peptide with striking results in mice — and essentially no human evidence for any of the claims made about it.
What it is
MOTS-c is a short peptide encoded not in the cell nucleus but in mitochondrial DNA — one of a small group of mitochondrial-derived peptides discovered in the last twenty years. It appears to act as a signal about the cell's energy state.
Composition
A sixteen-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA gene. What is sold online is a research chemical.
Proposed mechanism
It appears to act partly through the AMPK pathway — the same low-energy sensor that exercise and fasting activate — influencing glucose handling and fat metabolism. This is why it gets described as an exercise mimetic.
Claimed benefits
Improved insulin sensitivity, fat loss, better endurance, and slowed ageing.
What the evidence shows
Unproven· animal data only. The striking results are real and they are in mice: treated animals showed improved insulin sensitivity, resistance to diet-induced obesity and better running capacity. No controlled human trial has tested any of the physique or performance claims made for it.
The longevity angle rests on observation rather than intervention: MOTS-c levels fall with age, and certain genetic variants are more common in long-lived Japanese populations. That is an association in a legitimate line of ageing research, not a demonstrated effect of taking it.
Legal & regulatory status
Not a licensed medicine anywhere. As a non-approved substance it falls in a prohibited category under WADA rules at all times.
Known risks & unknowns
Essentially unknown in humans, because the human studies have not been done. That is the honest position: no established side-effect profile, no long-term data, and an unregulated product of unverifiable purity.
Sources
Frequently asked questions
- What is MOTS-c?
- A short peptide encoded not in the cell nucleus but in mitochondrial DNA — one of a small group of mitochondrial-derived peptides discovered in the last twenty years. It appears to act as a signal about cellular energy status, working partly through the AMPK pathway that exercise and fasting also activate.
- Is MOTS-c 'exercise in a pill'?
- That framing comes from mouse studies where treated animals showed improved insulin sensitivity, resistance to diet-induced obesity and better running capacity. Those findings are real and are why the peptide is of scientific interest. They are also in mice, and no controlled human trial has tested any of the physique or performance claims made for it.
- Does MOTS-c have anything to do with longevity?
- Levels fall with age and certain genetic variants of it are more common in long-lived Japanese populations, which is an association rather than a demonstrated cause. It is a legitimate line of ageing research, not a demonstrated intervention.
- Is MOTS-c banned in sport?
- It is a non-approved substance, which places it in a prohibited category under WADA rules at all times. Athletes should treat it as banned.
Related compounds
- Epithalon (Unproven)
An evidence-tiered explainer on epithalon: a synthetic peptide marketed for longevity and telomere lengthening, whose human evidence is limited, dated and far from establishing any anti-ageing effect.
- GLP-1 receptor agonists (Gold)
How GLP-1 receptor agonists (semaglutide, tirzepatide) differ from the unregulated 'research peptides': real large-scale trials, regulatory approval, and prescription-only status.
- IGF-1 LR3 (Unproven)
An evidence-tiered explainer on IGF-1 LR3: a modified growth factor sold as a muscle builder that was created as a cell-culture reagent and never tested in people.
Written and reviewed by Mathew Beale, MSc Biotechnology, University of Reading.
Last reviewed: